Loading insider details...
Beta
Latest Form 4 (Jun 8, 2026): Grant/Award of 4,545 RPRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 8, 2026 | Royalty Pharma plc (RPRX) | Grant/Award | 4,545 | n/a |
| Aug 14, 2025 | Denali Therapeutics Inc. (DNLI) | Sale | 2,937 | $39.9K |
| Aug 7, 2025 | Denali Therapeutics Inc. (DNLI) | Exercise/Conversion | 44,655 | $30.4K |
| Aug 1, 2025 | Royalty Pharma plc (RPRX) | Grant/Award | 2,752 | n/a |
| Jun 6, 2025 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 33,662 | n/a |
| Jan 8, 2025 | Denali Therapeutics Inc. (DNLI) | Sale | 12,255 | $247.8K |
| Jan 7, 2025 | Denali Therapeutics Inc. (DNLI) | Grant/Award | 54,180 | n/a |
| Nov 27, 2024 | Denali Therapeutics Inc. (DNLI) | Exercise/Conversion | 17,845 | $12.1K |
| Aug 22, 2024 | Denali Therapeutics Inc. (DNLI) | Sale | 2,453 | $58.4K |
| Aug 15, 2024 | Denali Therapeutics Inc. (DNLI) | Sale | 2,337 | $53.5K |